Wednesday, 8 April 2020

Aurobindo Pharma and Emcure Pharma faces $124 million lawsuit in US for concealing facts

A lawsuit is filed against Aurobindo Pharma and Emcure Pharma by MSP Recovery Claims in Florida, USA which claims that these pharmaceutical companies hide details about presence of carcinogenic element in anti-diabetic medicines reported by law360.



source https://www.pharmatutor.org/pharma-news/2020/aurobindo-pharma-and-emcure-pharma-faces-usd-124-million-lawsuit-in-usa-for-concealing-facts

No comments:

Post a Comment

Pharmaceutical Industry and pharma / Life Sciences institute openings 2025

  Intas Pharma Walk in Drive for M.Pharm, B.Pharm | Multiple Posts M.Pharma / B.Pharma. Injectable/Parenteral/Sterile - Aseptic, Manufacturi...